DK0599914T3 - Farmakologiske forbedrede formuleringer - Google Patents

Farmakologiske forbedrede formuleringer

Info

Publication number
DK0599914T3
DK0599914T3 DK92917294.8T DK92917294T DK0599914T3 DK 0599914 T3 DK0599914 T3 DK 0599914T3 DK 92917294 T DK92917294 T DK 92917294T DK 0599914 T3 DK0599914 T3 DK 0599914T3
Authority
DK
Denmark
Prior art keywords
improved formulations
pharmacologically
pharmacologically improved
formulations
micronized
Prior art date
Application number
DK92917294.8T
Other languages
Danish (da)
English (en)
Inventor
Sung J Lee
Original Assignee
Biofor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biofor Inc filed Critical Biofor Inc
Application granted granted Critical
Publication of DK0599914T3 publication Critical patent/DK0599914T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Cosmetics (AREA)
  • Lubricants (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DK92917294.8T 1991-04-05 1992-03-31 Farmakologiske forbedrede formuleringer DK0599914T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/680,997 US5271944A (en) 1991-04-05 1991-04-05 Pharmacologically enhanced formulations

Publications (1)

Publication Number Publication Date
DK0599914T3 true DK0599914T3 (da) 1998-03-02

Family

ID=24733350

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92917294.8T DK0599914T3 (da) 1991-04-05 1992-03-31 Farmakologiske forbedrede formuleringer

Country Status (16)

Country Link
US (1) US5271944A (fr)
EP (1) EP0599914B1 (fr)
AT (1) ATE155687T1 (fr)
AU (1) AU1876792A (fr)
CA (1) CA2052901C (fr)
CH (1) CH683824A5 (fr)
DE (1) DE69221150T2 (fr)
DK (1) DK0599914T3 (fr)
ES (1) ES2108130T3 (fr)
FR (1) FR2674754B1 (fr)
IE (1) IE74211B1 (fr)
IT (1) ITTO920303A1 (fr)
NZ (1) NZ242233A (fr)
PT (1) PT100329B (fr)
WO (1) WO1992017163A1 (fr)
ZA (1) ZA922482B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2684298B1 (fr) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
CN1090935C (zh) * 1995-02-28 2002-09-18 阿温蒂斯药物公司 哌啶子基烷醇化合物的药物组合物
NZ501248A (en) * 1997-08-26 2001-06-29 Aventis Pharma Inc Pharmaceutical composition for combination of piperidinoalkanol-decongestant
DE60125429T2 (de) * 2000-04-24 2007-09-27 Teva Pharmaceutical Industries Ltd. Zolpidem hemitartrat solvat
EP1473036B1 (fr) 2000-04-24 2006-08-09 Teva Pharmaceutical Industries Ltd. Zolpidem hemitartrate comme solvate
AU2002244247B2 (en) 2001-03-01 2007-12-13 Harbor Biosciences, Inc. Use of certain steroids for treatment of blood cell deficiencies
US6861066B2 (en) * 2002-03-11 2005-03-01 Health Plus International Inc. Method for the delivery of a biologically active agent
US20060280761A1 (en) * 2002-03-11 2006-12-14 Health Plus International, Inc. Nanofluidized B-12 composition and process for treating pernicious anemia
BE1015641A4 (fr) * 2003-05-26 2005-07-05 Mariani Jean Paul Micronisation 70.
WO2005037821A2 (fr) * 2003-10-16 2005-04-28 Teva Pharmaceutical Industries Ltd. Preparation de candesartan cilexetil
ATE387203T1 (de) * 2004-01-05 2008-03-15 Teva Pharma Prozesse zur herstellung von sildenafil-base und zitratsalz
EP1713795A2 (fr) * 2004-02-11 2006-10-25 Teva Pharmaceutical Industries Ltd. Polymorphes de candesartan cilexetil
CA2582231A1 (fr) 2004-09-29 2006-10-19 Hollis-Eden Pharmaceuticals, Inc. Analogues de steroides et leurs utilisations
PT2273994E (pt) 2008-04-03 2016-03-15 Neurmedix Inc Formas de estado sólido de um produto farmacêutico
TW201613888A (en) 2014-09-26 2016-04-16 Helsinn Healthcare Sa Crystalline forms of an NK-1 antagonist

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
DE3204126A1 (de) * 1982-02-06 1983-08-11 Bayer Ag, 5090 Leverkusen Pyrazoloxazine, -thiazine, -chinoline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
US4912093A (en) * 1986-10-01 1990-03-27 Marion Laboratories, Inc. Use of synthetic sulfated saccharides to enhance wound healing
DE3723327A1 (de) * 1987-07-15 1989-02-02 Hoechst Ag Substituierte thienoimidazol-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer, magenschutzmittel sowie als medikament gegen intestinale entzuendungen
US4892870A (en) * 1988-08-01 1990-01-09 Biofor, Ltd. Oxaza heterocycles and pharmaceutical compositions containing same

Also Published As

Publication number Publication date
ATE155687T1 (de) 1997-08-15
FR2674754B1 (fr) 1994-01-14
DE69221150T2 (de) 1998-02-26
NZ242233A (en) 1993-07-27
CH683824A5 (de) 1994-05-31
CA2052901C (fr) 1997-12-23
WO1992017163A1 (fr) 1992-10-15
ES2108130T3 (es) 1997-12-16
US5271944A (en) 1993-12-21
EP0599914A4 (en) 1994-08-24
AU1876792A (en) 1992-11-02
ZA922482B (en) 1992-12-30
FR2674754A1 (fr) 1992-10-09
EP0599914A1 (fr) 1994-06-08
ITTO920303A0 (it) 1992-04-02
PT100329B (pt) 1999-06-30
EP0599914B1 (fr) 1997-07-23
DE69221150D1 (de) 1997-09-04
PT100329A (pt) 1993-07-30
IE921040A1 (en) 1992-10-07
IE74211B1 (en) 1997-07-16
ITTO920303A1 (it) 1992-10-05
CA2052901A1 (fr) 1992-10-06

Similar Documents

Publication Publication Date Title
ATE155687T1 (de) Pharmakologisch verbesserte formulierungen
SE8300736D0 (sv) Novel pharmacologically active compounds
LV10907A (lv) Interferona polietilenglikola atvasinajums
SV1997000049A (es) Conjugados de interferones ref. 12614 sv
CR6210A (es) Composiciones de celecoxib
DE3679722D1 (de) Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung.
LU91223I2 (fr) Ivabradine et ses dérivés pharmaceutiquement acceptables (procoralan)
CA2104461A1 (fr) Compositions therapeutiques de protection et de reanimation de cellules de mammiferes et methode pour leur preparation et utilisation
DK0598770T3 (da) Pyrazinderivater samt fremstilling og anvendelse deraf
GR3019274T3 (en) Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use
ATE134294T1 (de) Zusammensetzung mit psyllium
JPS5781409A (en) External plaster
SE8306225L (sv) 2-piperazinyl-kinazolinderivat, deras framstellning och farmaceutiska kompositioner innehallande desamma
DK0524696T3 (da) Orale præparater indeholdende dapiprazol
ATE103890T1 (de) Neue acylaminosaeurederivate enthaltende arzneimittel und diaetetika.
IT1187743B (it) Composizioni farmaceutiche a base di destrorfano per applicazione instranasale
ATE44461T1 (de) Analgetische zusammensetzungen.
IT1243358B (it) Composizioni farmaceutiche per la somministrazione orale di irudina
SE8502876D0 (sv) Inhibition of tumor development
DK0483320T3 (da) Farmaceutiske sammensætninger med forlænget frigivelse til peroral indgivelse og fremgangsmåde til fremstilling deraf
SE8104675L (sv) Farmacevtisk komposition med antiflogistisk, antipyretisk och analgetisk verkan
DE68903713D1 (de) Dextrorphansalze enthaltende orale arzneimittel.
SE8700829L (sv) Farmaceutisk komposition
ES2135424T3 (es) Composicion oral a base de ibuprofeno.
KR930004460A (ko) 에이(a) 87689 화합물